-
Five cases of demyelinating neuropathy are reported as a consequence of treatment with anti-tumor necrosis factor drugs for auto-immune disorders.
-
Many of the disabling symptoms of Parkinson's disease are unrelated to nigrostriatal dopamine deficiency, and unresponsive to dopamine replacement therapy.
-
NSAIDs in the elderly; managing GI and CVD risk with NSAIDs; low-dose naltrexone and fibromyalgia; treating glucocorticoid-induced bone loss; FDA Actions.
-
Repetitive transcranial magnetic stimulation appears to be a safe and effective method to treat chronic tinnitus.
-
This pilot study reports on the long-term efficacy, safety, and adverse events of focused radiosurgery as an alternative to temporal lobectomy for mesial temporal lobe epilepsy.
-
Botulinum toxin type B injection into the parotid glands is safe and effective for PD-related drooling, with duration of action of 3–6 months.
-
-
This study showed that surrogate decision-makers with a loved one in the ICU want clinicians to discuss the patient's prognosis, even if it is uncertain.
-
The introduction of drug-eluting stents (DES) was met with enthusiasm from the interventional cardiology community because of the dramatic reduction in rates of in-stent restenosis (ISR). However, it came to be recognized that this clinical benefit, due to reduced proliferation of smooth muscle cells, came at a price.
-
When 4 different interfaces with varying internal dead space were randomly applied during non-invasive ventilation in 14 patients with acute respiratory failure, there were no significant differences in gas exchange, minute ventilation, or work of breathing, but patient tolerance of the different devices varied substantially.
